CrushSCI.com
提供学术论文选刊润色服务
MEDICAL ONCOLOGY 期刊封面 医学
返回期刊列表

Review Cycle Records

MEDICAL ONCOLOGY

Springer SCIE 非OA
2026新锐 3区2025中科院 4区2025 JCR Q2
57.8平均天数
46.5中位天数
11最短天数
121最长天数
6242025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

39 天

Ambient air emissions of endocrine-disrupting metals and the incidence of hormone receptor- and HER2-dependent female breast cancer in USA

作者Esther Ro; Vivian Vu; Yudan Wei

作者单位1. MD Program, Mercer University School of Medicine, Macon, USA; 2. Department of Internal Medicine at Atrium Health Carolinas Medical Center, Charlotte, USA; 3. Department of Community Medicine, Mercer University School of Medicine, Macon, USA

PDF源文件 DOI 网页
11 天

How to ensure uninterrupted treatment of radiotherapy patients during delta variants of SARS-CoV-2 virus epidemic: the latest experience from Xi’an, China

作者Yongkai Lu; Ruijuan Chen; Yi Li

作者单位1. Department of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China; 2. Xi’an Central Hospital, The Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

PDF源文件 DOI 网页
37 天

In-vitro analysis on the potential use of dental pulp mesenchymal stem cells on arecoline-induced oral epithelial cells

作者Archana A. Gupta; Supriya Kheur; Saranya Varadarajan; Chandini Rajkumar; Vikrant R. Patil

作者单位1. Department of Oral Pathology and Microbiology, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, India; 2. Department of Oral Pathology and Microbiology, Sri Venkateswara Dental College and Hospital, Chennai, India; 3. Department of Oral Pathology and Microbiology, Sathyabama Dental College and Hospital, Chennai, India; 4. Biogenre Private Limited, Pune, India

PDF源文件 DOI 网页
77 天

Innovation in cancer therapeutics and regulatory perspectives

作者Pinky Sharma; Vikas Jhawat; Pooja Mathur; Rohit Dutt

作者单位1. School of Medical and Allied Sciences, GD Goenka University, Gurugram, India

PDF源文件 DOI 网页
117 天

DNA methylation marker to estimate ovarian cancer cell fraction

作者Takahiro Ebata; Satoshi Yamashita; Hideyuki Takeshima; Hiroshi Yoshida; Yoshiko Kawata; Nao Kino; Toshiharu Yasugi; Yasuhisa Terao; Kan Yonemori; Tomoyasu Kato; Toshikazu Ushijima

作者单位1. Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan; 2. Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan; 3. Department of Gynecology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan; 4. Department of Obstetrics and Gynecology, Juntendo University, Tokyo, Japan; 5. Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan; 6. Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan

PDF源文件 DOI 网页
121 天

Forward to a methodological proposal to support cancer patients: the dialogics’ contribution for the precision care

作者Eleonora Pinto; Rita Alfieri; Luisa Orrù; Marta Silvia Dalla Riva; Gian Piero Turchi

作者单位1. Unit of Surgical Oncology of the Esophagus and Digestive Tract, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy; 2. Department of Philosophy, Sociology, Pedagogy and Applied Psychology, University of Padua, Padua, Italy

PDF源文件 DOI 网页
23 天

Knockout of high-mobility group box 1 in B16F10 melanoma cells induced host immunity-mediated suppression of in vivo tumor growth

作者Kanako Yokomizo; Kayoko Waki; Miyako Ozawa; Keiko Yamamoto; Sachiko Ogasawara; Hirohisa Yano; Akira Yamada

作者单位1. Cancer Vaccine Development Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Japan; 2. Department of Pathology, Kurume University School of Medicine, Kurume, Japan

PDF源文件 DOI 网页
26 天

Effects of metformin on human bone-derived mesenchymal stromal cell—breast cancer cell line interactions

作者Maryana Teufelsbauer; Clemens Lang; Adelina Plangger; Barbara Rath; Doris Moser; Clement Staud; Christine Radtke; Christoph Neumayer; Gerhard Hamilton

作者单位1. Department of Plastic and Reconstructive Surgery, Medical University of Vienna, Vienna, Austria; 2. Department of Trauma Surgery, Sozialmedizinisches Zentrum Ost, Donauspital, Vienna, Austria; 3. Institute of Pharmacology, Medical University of Vienna, Vienna, Austria; 4. Department of Cranio, Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria; 5. Department of Vascular Surgery, Medical University of Vienna, Vienna, Austria

PDF源文件 DOI 网页
54 天

ERCC6L is a biomarker and therapeutic target for non–small cell lung adenocarcinoma

作者Guoxin Hou; Zhimin Lu; Yanyu Bi; Jingjing Deng; Xinmei Yang

作者单位1. Department of Oncology, The First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, Jiaxing, China; 2. Department of Outpatient, The First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, Jiaxing, China; 3. Department of Respiratory, The First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, Jiaxing, China

PDF源文件 DOI 网页
73 天

Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma

作者Hua Zhang; Jintong Chen; Mingyue Zhang; Munan Zhao; Luyao Zhang; Bin Liu; Siqing Wang

作者单位1. Department of Gastrointestinal Surgery, The First Hospital of Jilin University, Changchun, China; 2. Department of Cancer Immunology, The First Hospital of Jilin University, Changchun, China; 3. Department of Gynecological Oncology, The First Hospital of Jilin University, Changchun, China; 4. Department of Cancer Center, The First Hospital of Jilin University, Changchun, China; 5. Department of Hand and Foot Surgery, The First Hospital of Jilin University, Changchun, China

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。